Cargando…

Visit Adherence of Mild to Moderate Psoriasis Patients: A Mobile-Based Randomized Study

OBJECTIVE: We aimed to prospectively evaluate the visit adherence in mild to moderate psoriasis patients. METHODS: Plaque psoriasis patients aged 18 or above who were prescribed with a two-component formula ointment were eligible for the study. The patients were randomly assigned to group A or B, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yi, Wang, Gang, Ni, Wenqiong, Song, Zhiqiang, Chen, Kun, Zhang, Chunlei, Zhang, Shoumin, Ding, Yangfeng, Zheng, Min, Shi, Yulin, Lin, Zhimiao, Liu, Xiaomin, Zhang, Xiaofei, Zhou, Qintian, Ahmed, Kazi Deluwar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802013/ https://www.ncbi.nlm.nih.gov/pubmed/33447016 http://dx.doi.org/10.2147/PPA.S277103

Ejemplares similares

Treatment outcomes of secukinumab in adult patients with moderate‐to‐severe plaque psoriasis in China: A real‐world multicenter retrospective study
por: Ding, Yangfeng, et al.
Publicado: (2023)

Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy
por: Imafuku, Shinichi, et al.
Publicado: (2018)

Carotid intima-media thickness in patients with mild or moderate psoriasis
por: Bańska-Kisiel, Katarzyna, et al.
Publicado: (2016)

Novel topical therapy for mild-to-moderate plaque psoriasis: focus on calcitriol
por: Kowalzick, Lutz
Publicado: (2009)

Blood microRNA expressions in patients with mild to moderate psoriasis and the relationship between microRNAs and psoriasis activity()()
por: Alatas, Emine Tugba, et al.
Publicado: (2020)

Discovery of a novel RORγ antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasis
por: Liu, Suxing, et al.
Publicado: (2021)

Mutational analysis of epidermal and hyperproliferative type I keratins in mild and moderate psoriasis vulgaris patients: a possible role in the pathogenesis of psoriasis along with disease severity
por: Elango, Tamilselvi, et al.
Publicado: (2018)

Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis
por: Langewouters, A. M. G., et al.
Publicado: (2007)

Cholesterol efflux capacity is associated with lipoprotein size and vascular health in mild to moderate psoriasis
por: Berg, Alexander R., et al.
Publicado: (2023)

Topical Treatment for the Management of Mild-to-Moderate Psoriasis: A Critical Appraisal of the Current Literature
por: Fargnoli, Maria Concetta, et al.
Publicado: (2023)

The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study
por: Xu, Xin, et al.
Publicado: (2017)

A Randomized, Double-Blind, Controlled Clinical Study on the Curative Effect of Huaier on Mild-to-Moderate Psoriasis and an Experimental Study on the Proliferation of Hacat Cells
por: Su, Dongqiang, et al.
Publicado: (2018)

Liangxue Jiedu Runzhi ointment in the treatment of mild and moderate psoriasis with blood-heat syndrome: A double-blind randomized controlled trial
por: Qiu, Yue, et al.
Publicado: (2022)

Efficacy and Safety of Jueyin Granules for Patients with Mild-to-Moderate Psoriasis Vulgaris: Protocol for a Multicenter Randomized Placebo-Controlled Trial
por: Li, Su, et al.
Publicado: (2020)

Effect of governor vessel moxibustion (GVM) therapy with mild to moderate psoriasis: A randomized clinical trial
por: Sun, Dan, et al.
Publicado: (2023)

Therapy of moderate and severe psoriasis
por: Claes, Christa, et al.
Publicado: (2006)

Skin Picking in Atopic Dermatitis and Psoriasis Patients: A Single-centre Cross-sectional Study in China
por: JU, Yanjiao, et al.
Publicado: (2022)

A New Classification of the Severity of Psoriasis: What’s Moderate Psoriasis?
por: Salgado-Boquete, Laura, et al.
Publicado: (2021)

Feasibility and usability of a digital health technology system to monitor mobility and assess medication adherence in mild-to-moderate Parkinson's disease
por: Debelle, Héloïse, et al.
Publicado: (2023)

Topical nicotinamide in combination with calcipotriol for the treatment of mild to moderate psoriasis: A double-blind, randomized, comparative study
por: Siadat, Amir Hossein, et al.
Publicado: (2013)

Mild-to-moderate severity of psoriasis may be assessed remotely based on photographs and self-reported extent of skin involvement
por: Ali, Zarqa, et al.
Publicado: (2023)

Efficacy and safety of a topical moisturizer containing linoleic acid and ceramide for mild‐to‐moderate psoriasis vulgaris: A multicenter randomized controlled trial
por: Li, Xia, et al.
Publicado: (2020)

A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis
por: Cai, Lin, et al.
Publicado: (2020)

The Extra Cost Due to Non-Adherence to Inhaled Treatments in Adolescents with Mild-to-Moderate Persistent Asthma
por: Dal Negro, Roberto Walter, et al.
Publicado: (2023)

Treatment Approaches to Moderate to Severe Psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2017)

Association of Wildfire Air Pollution With Clinic Visits for Psoriasis
por: Fadadu, Raj P., et al.
Publicado: (2023)

Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation
por: Colombo, Giorgio L, et al.
Publicado: (2012)

Characterizing Outcomes and Unmet Needs Among Patients in the United States with Mild-to-Moderate Plaque Psoriasis Using Prescription Topicals
por: Gupta, Shaloo, et al.
Publicado: (2021)

Sex differences in the association between plasma polyunsaturated fatty acids levels and moderate-to-severe plaque psoriasis severity: a cross-sectional and longitudinal study
por: Wang, Xin, et al.
Publicado: (2023)

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
por: Jiang, Yuxiong, et al.
Publicado: (2023)

Comparison in Adherence to Treatment between Patients with Mild–Moderate and Severe Reflux Esophagitis: A Prospective Study
por: Mari, Amir, et al.
Publicado: (2022)

Phase I randomized study of KHK4083, an anti‐OX40 monoclonal antibody, in patients with mild to moderate plaque psoriasis
por: Papp, K.A., et al.
Publicado: (2017)

The effect of Melissa officinalis syrup on patients with mild to moderate psoriasis: a randomized, double-blind placebo-controlled clinical trial
por: Yargholi, Alireza, et al.
Publicado: (2021)

Bullous Pemphigoid Associated with Erythrodermic Psoriasis: A Case Report
por: Chen, Wenjuan, et al.
Publicado: (2022)

Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis
por: Suárez-Fariñas, Mayte, et al.
Publicado: (2012)

Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis
por: Golhen, Klervi, et al.
Publicado: (2022)

Efficacy and Safety of HLX03, an Adalimumab Biosimilar, in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blind, Phase III Study
por: Cai, Lin, et al.
Publicado: (2021)

Pharmacokinetics of Risankizumab in Asian Healthy Subjects and Patients With Moderate to Severe Plaque Psoriasis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis
por: Khatri, Amit, et al.
Publicado: (2019)

Superiority of a vitamin B(12)-containing emollient compared to a standard emollient in the maintenance treatment of mild-to-moderate plaque psoriasis
por: Del Duca, Ester, et al.
Publicado: (2017)

Efficacy of a Topical Formulation of Sodium Bicarbonate in Mild to Moderate Stable Plaque Psoriasis: a Randomized, Blinded, Intrapatient, Controlled Study
por: Mazzarello, Vittorio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_71gnin37q1h8dag0r3263018l3